HTT and Huntington disease: Although Integrity Pathway Disease analysis included Huntington's disease as an affected pathway, the breadth of gene dysregulation suggests that gene dysregulation by Htt-exon1-GFP (Q103) is nonspecific with respect to any group of genes or pathways, consistent with observations from other laboratories (reviewed by [22, 23]).